{
    "SPADE_UN_14146": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_14146",
            "Peptide Name": "Temporin L[Pro3,DLeu9,Pro10](TL2)",
            "Source": "Synthetic construct(derived from Temporin-L)",
            "Family": "Coronaviridae, Herpesviridae, Paramyxoviridae",
            "Gene": "Not found",
            "Sequence": "FVPWFSKFLPRIL",
            "Sequence Length": 13,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=7.70 μM,IC90=18.76 μM);HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=9.83 μM μM,IC90=19.20 μM);SARS-CoV-2:inhibition of  replication in Vero cells(IC50=4.82 μM μM,IC90=13.98 μM);HPIV-3:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);HCoV-229E:inhibition of replication in Vero cells(IC50=10.56 μM,IC90=50.00 μM);HCoV-OC43:inhibition of replication in Vero cells(IC50=11.31 μM,IC90=24.13 μM).",
            "Hemolytic Activity": "[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.",
            "Cytotoxicity": "[Ref.35216177]Vero cells:CC50= 56.52 μM",
            "Binding Target": "membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "Mixed(D-Leu9)",
            "Structure Description": "Not found",
            "Formula": "C80H111N17O13",
            "Mass": 1650.02,
            "PI": 11.0,
            "Net Charge": 2,
            "Hydrophobicity": 0.88,
            "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min",
            "Mechanism of action": "TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.",
            "Literature": [
                {
                    "Title": "Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.",
                    "Pubmed ID": "35216177",
                    "Reference": "Int J Mol Sci. 2022 Feb 13;23(4)2060.",
                    "Author": "Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=35216177"
                }
            ],
            "Frequent Amino Acids": "FLP",
            "Absent Amino Acids": "ACDEGHMNOQTUY",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 4,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_14146",
                    "Similarity": 1.0,
                    "Sequence": "FVPWFSKFLPRIL"
                },
                {
                    "SPADE_ID": "SPADE_UN_14147",
                    "Similarity": 1.0,
                    "Sequence": "FVPWFSKFLPRIL"
                },
                {
                    "SPADE_ID": "SPADE_UN_14148",
                    "Similarity": 1.0,
                    "Sequence": "FVPWFSKFLRIL"
                }
            ]
        }
    }
}